Last reviewed · How we verify
NCT05368922: RV-REEDUC
Upper Limb Rehabilitation Using Virtual Reality in Children With Cerebral Palsy (RV-REEDUC)
NA trial testing Virtual reality rehabilitation in Cerebral Palsy in 20 participants. Completed in 28 February 2023.
1 February 2023
Quick facts
| Lead sponsor | Slb Pharma |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 22 April 2022 |
| Primary completion | 1 February 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 3 locations across France |
Drugs / interventions tested
- Virtual reality rehabilitation
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Brain Diseases — all drugs for Brain Diseases →
Sponsor
Slb Pharma
Who can join
Adults 8 to 16, any sex, with Cerebral Palsy or Brain Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of a virtual reality rehabilitation protocol on visuo-motor coordination and upper limb functional abilities in children with unilateral or bilateral cerebral palsy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05368922
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Virtual reality rehabilitation
Trials testing the same drug.
- NCT06094335 — Effect of Virtual Reality on Balance in Autism · NA · completed
- NCT03865641 — Effects of Virtual Reality Based Rehabilitation on Burned Hands · NA · completed
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other Slb Pharma trials
Trials by the same sponsor.
- NCT07063810 — NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study. · NA · not yet recruiting
- NCT04311268 — Follow Fever to Decide · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05368922 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Slb Pharma
- Last refreshed: 6 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05368922.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing